(Q54702413)
Statements
Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-alpha/beta-inducible gene expression, without significant toxicity (English)
Jonathan W Friedberg
Helen Kim
Mary McCauley
Paul Sims
David C Fisher
Robert L Coffman
Arnold S Freedman